NCT06138210 - The Effect of GD-iExo-003 in Acute Ischemic Stroke | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 27, 2024

Primary Completion Date

August 30, 2025

Study Completion Date

August 30, 2025

Conditions

Acute Ischemic Stroke

Interventions

DRUG

exosomes derived from human induced pluripotent stem cell for injection

Exosomes derived from human induced pluripotent stem cell for injection (3.0ml, 1×10\^11particles/ml).

DRUG

a placebo of exosomes derived from human induced pluripotent stem cell for injection

Exosomes placebo, 3.0ml

Trial Locations (1)

RECRUITING

Xuanwu Hospital, Capital Medical University, Beijing